diabetes - Nursing Case Study
Pathophysiology
• Primary mechanism: Insulin resistance - In type 2 diabetes, cells in muscles, fat, and the liver become less responsive to insulin, a hormone that facilitates glucose uptake into cells. This leads to elevated blood glucose levels as glucose remains in the bloodstream.
• Secondary mechanism: Impaired insulin secretion - The pancreatic beta cells, which produce insulin, become dysfunctional over time. This reduces insulin production and exacerbates hyperglycemia, contributing to chronic high blood sugar levels.
• Key complication: Vascular damage - Persistent hyperglycemia damages blood vessels, increasing the risk of cardiovascular diseases, neuropathy, and retinopathy. This damage is due to glucose-induced oxidative stress and inflammation, which impair blood flow and organ function.
Patient Profile
Demographics:
62-year-old female, retired school teacher
History:
• Key past medical history: Type 2 diabetes diagnosed 10 years ago, hypertension, hyperlipidemia
• Current medications: Metformin 1000 mg twice daily, Lisinopril 10 mg daily, Atorvastatin 20 mg daily, Aspirin 81 mg daily
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Increasing fatigue and tingling in feet
• Key symptoms: Blurred vision, frequent urination, increased thirst, and numbness in extremities
• Vital signs: Blood pressure 150/95 mmHg, heart rate 88 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F, blood glucose level 210 mg/dL
Section 1
During the initial assessment, the patient's physical examination revealed several notable findings. The skin on her lower extremities appeared dry with diminished hair growth, and there was a noticeable decrease in vibratory sensation when tested with a tuning fork. Additionally, the patient exhibited decreased reflexes in her Achilles tendon bilaterally, consistent with peripheral neuropathy often seen in longstanding diabetes. Further examination of her eyes using a fundoscope revealed signs of background diabetic retinopathy, with microaneurysms and soft exudates present, which could explain her complaint of blurred vision. These assessment findings suggest that the patient's diabetes is contributing to both neuropathic and retinopathic complications, necessitating immediate attention to prevent further progression.
Laboratory results confirmed the presence of elevated HbA1c levels at 8.5%, indicating poor long-term blood glucose control. A lipid panel showed elevated LDL cholesterol at 140 mg/dL and triglycerides at 200 mg/dL, despite ongoing statin therapy, indicating suboptimal management of her hyperlipidemia. Given the combination of hypertension, hyperlipidemia, and diabetes, the patient is at increased risk for cardiovascular complications. The findings of peripheral neuropathy and retinopathy further highlight the need for comprehensive management strategies, including stricter glycemic control and potential medication adjustments to address her cardiovascular risk factors and prevent further vascular damage.
The healthcare team decided to initiate a more intensive diabetes management plan, including lifestyle modifications and potential pharmacological adjustments, such as considering a GLP-1 receptor agonist or SGLT2 inhibitor to help with glycemic control and cardiovascular protection. A referral to a podiatrist and ophthalmologist was also made for specialized care of her neuropathy and retinopathy. The immediate goal is to stabilize her blood glucose levels and address her cardiovascular risks, with the long-term aim of preventing further complications. This comprehensive approach is essential for improving the patient's quality of life and preventing further deterioration of her health status.
Section 2
Following the implementation of the intensified diabetes management plan, the patient returned for a follow-up appointment after six weeks. Despite adherence to the prescribed regimen, including the addition of a GLP-1 receptor agonist, the patient reported new onset of intermittent chest discomfort, particularly during physical exertion. This prompted further investigation, given her heightened cardiovascular risk profile. Physical examination revealed a blood pressure of 150/90 mmHg and a heart rate of 92 bpm, suggesting insufficient control of her hypertension. An electrocardiogram (ECG) was performed, showing non-specific ST segment changes, which raised suspicion for possible ischemic heart disease.
To further evaluate her cardiac status, a stress test was conducted, which indicated exercise-induced ischemia. Subsequent coronary angiography revealed significant stenosis in the left anterior descending artery. This finding aligned with her symptoms and necessitated a multidisciplinary approach to manage her cardiovascular condition. The cardiology team recommended percutaneous coronary intervention (PCI) to address the stenosis, alongside optimization of her antihypertensive and lipid-lowering therapies, emphasizing the need for rigorous management of her modifiable risk factors.
These developments underscore the interconnectedness of her diabetes, hypertension, and hyperlipidemia, highlighting the critical need for an integrated approach to her care. The healthcare team discussed the importance of continuing lifestyle modifications, including dietary adjustments and increased physical activity, in conjunction with medical interventions. The patient was educated on recognizing symptoms of angina and the significance of adhering to her revised medication regimen. This comprehensive strategy aims to enhance her overall cardiovascular health and prevent further complications, setting the stage for the next phase of her treatment journey.
Section 3
In the weeks following the percutaneous coronary intervention (PCI), the patient was closely monitored to evaluate her response to the interventions and the effectiveness of her new treatment plan. During a follow-up appointment, the patient reported a significant reduction in chest discomfort and an increase in her exercise tolerance. However, she mentioned experiencing occasional dizziness and fatigue, which prompted further assessment. Vital signs revealed a blood pressure of 130/85 mmHg and a heart rate of 80 bpm, suggesting improved but not yet optimal control of her cardiovascular status.
A review of her laboratory results showed a decrease in low-density lipoprotein (LDL) cholesterol levels to 98 mg/dL, reflecting the impact of intensified lipid-lowering therapy. However, her glycated hemoglobin (HbA1c) remained at 8.2%, indicating persistent challenges in glycemic control. Additionally, her renal function tests revealed a slight increase in creatinine levels to 1.3 mg/dL from a previous 1.1 mg/dL, raising concerns about potential diabetic nephropathy and the need for renal protective strategies.
These findings necessitated a reevaluation of her diabetes management plan, with a focus on optimizing glycemic control while ensuring renal protection. The healthcare team considered the introduction of an SGLT2 inhibitor, known for its benefits in both glucose control and renal protection. The team also emphasized the importance of continued lifestyle modifications and patient education to address the multifaceted nature of her condition. This comprehensive approach aims to stabilize her current symptoms, mitigate progression of complications, and set a foundation for improved long-term outcomes. As the patient moves forward in her treatment journey, the collaboration between her primary care provider, endocrinologist, and cardiologist will be crucial in tailoring her management plan to meet her evolving needs.
Section 4
In the weeks following the introduction of the SGLT2 inhibitor, the patient returned for a follow-up appointment, where she reported a noticeable improvement in her blood glucose levels, as well as a reduction in the episodes of dizziness and fatigue. Her self-monitored blood glucose readings indicated a downward trend, with fasting levels consistently ranging between 110-120 mg/dL. However, she also mentioned experiencing increased urinary frequency and mild dehydration symptoms, prompting the healthcare team to closely monitor her renal function and hydration status.
During this visit, her vital signs were stable, with a blood pressure of 125/80 mmHg and a heart rate of 78 bpm. Laboratory tests showed a slight improvement in HbA1c, now at 7.8%. However, her creatinine level had increased marginally to 1.4 mg/dL, which suggested a need for cautious monitoring to prevent further renal impairment. Additionally, a urine albumin-to-creatinine ratio was performed, revealing a slight increase in microalbuminuria, indicating early signs of diabetic nephropathy that needed to be addressed promptly.
The healthcare team decided to enhance her renal protective strategy by optimizing her antihypertensive regimen with an ACE inhibitor, aiming to prevent further kidney damage. They also emphasized the importance of maintaining proper hydration, especially given the diuretic effect of the SGLT2 inhibitor. Collaborative discussions with the patient highlighted the critical role of adhering to lifestyle modifications, such as dietary adjustments and regular physical activity, to complement her pharmacological treatment. This integrated approach aimed to stabilize her renal function while continuing to improve her glycemic control, setting the stage for further evaluation and potential adjustments in her management plan. As the patient continued her journey, ongoing coordination among her healthcare providers was essential to address the evolving complexities of her condition effectively.
Section 5
In the subsequent follow-up visit, the patient reported a significant improvement in her energy levels and noted fewer episodes of dizziness. However, she expressed concerns about experiencing occasional swelling in her lower extremities and a recent episode of shortness of breath during mild exertion. These new symptoms prompted the healthcare team to conduct a thorough cardiovascular assessment, given the patient's ongoing risk factors and the recent addition of the ACE inhibitor to her treatment regimen.
During the examination, her vital signs revealed a slight elevation in blood pressure at 130/85 mmHg and a heart rate of 82 bpm. Auscultation of her lungs indicated mild bilateral crackles at the bases, suggesting possible fluid overload. Laboratory tests showed stable blood glucose levels, but a serum BNP (B-type natriuretic peptide) was elevated at 250 pg/mL, raising suspicion for early heart failure. Additionally, an echocardiogram was scheduled to assess cardiac function and evaluate the extent of any potential cardiac involvement.
These findings led the healthcare team to adjust her treatment plan by cautiously optimizing her diuretic therapy to manage fluid retention while monitoring her renal function closely. Patient education focused on recognizing early signs of fluid overload and adhering to a low-sodium diet. The integrated care approach highlighted the importance of balancing her glycemic control with cardiovascular management, underscoring the interconnected nature of diabetes-related complications. As the patient continued on her path, the healthcare team maintained vigilant surveillance to preemptively address any further complications and sustain her overall health and wellbeing.